http://www.fpnotebook.com/
Obesity Surgery
Aka: Obesity Surgery, Roux-en-Y gastric bypass, Vertical Banded Gastroplasty, Distal Gastric Bypass, Biliopancreatic Diversion, Gastric Bypass, Gastroplasty, Bariatric Surgery
Indication: Obesity Body Mass Index (BMI) >= 40 kg/m2Body Mass Index (BMI) >= 35 kg/m2 with comorbidity (e.g. Diabetes, Cardiomyopathy )
ContraindicationsHigh risk cardiopulmonary disease Ongoing Drug Abuse , Alcohol Abuse or other uncontrolled mental health disorder Reversible pathologic causes of Obesity (e.g. endocrine disorder) Poor insight into the risks, benefits, lifestyle investment, alternative options, or expected outcomes
Procedures: CommonRoux-en-Y gastric bypass (RYGB)Gold standard method today DescriptionStomach partitioned into 20 ml pouchPouch anastomosed to jejunum Remainder of Stomach and duodenum bypassed Efficacy: Weight loss 30-40% at 1 year and 25% at 10 years Perioperative mortality: <0.3% DisadvantagesMalabsorption of iron, B12 and calcium Technically difficult with higher morbidity Laparoscopic Adjustable Gastric Banding (introduced in 2006)Reversible and tension can be adjusted via port Replaces Vertical Banded Gastroplasty Weight loss 21% at 1 year and 13% at 10 years
Procedures: Other newer proceduresBiliopancreatic Diversion (introduced in 2004)Very effective in super-obese patients (BMI>50 kg/m) Weight loss 40% at 1 year and 30-40% at 10 years Gastric Sleeve (introduced in 2008)Lateral Stomach excised leaving a smaller residual Stomach pouch Promising new procedure with high efficacy and lower adverse effects (e.g. no dumping)
Procedures: Not recommendedJejunoileal Bypass (Distal Gastric Bypass)Less commonly performed since 1985 (with a few exceptions) Vertical Banded Gastroplasty (VBG or Stomach stapling)Less commonly performed since 1989 due to low long-term efficacyReplaced by Adjustable Gastric Banding EfficacyAt 3 years: 40-63% excess Weight Reduction At 10 years: 20% excess Weight Reduction DisadvantagesLess effective than Roux-en-Y Procedure High surgical revision rate (41-45%)Due to high rate of staple dehiscence Once staple line opens, weight gain returns Higher risk of stricture or GERD Perioperative mortality: 0-1.0% These procedures not recommended by NIH panelSignificantly higher risk of complications
Complications: Acute serious complicationsPerioperative MortalityProcedure TypeRoux-en-Y gastric bypass (RYGB): <0.3% mortality Biliopancreatic Diversion (BPD-DS): <0.3% mortality Laparoscopic Adjustable Gastric Banding (LAGB): <0.1% mortality Patient factors: Highest riskBody Mass Index (BMI) over 60 kg/m2: 3% mortalityAge over 60 years: 1% mortality Patient factors: Additive risks (Mortality increases from 0.2% up to 2.4% if at least 4 criteria are present)Age over 45 years old Hypertension Male gender Pulmonary Embolism risk (DVT history, Pulmonary Hypertension , Obesity -related hypoventilation)Body Mass Index >50 Thromboembolic complicationsSee peri-operative thromboembolism prophylaxis below Anastomotic Leak (and secondary Sepsis )Leak at anastomosis or banding site Requires emergency evaluation PresentationSevere Abdominal Pain Fever Hypotensive shock Heart Rate over 120 associated with Abdominal Pain increases Specificity EvaluationCT Abdomen with contrast (only 60% sensitive) Urgent surgical consultationMay require exploration despite negative CT Abdomen Internal Hernia (occurs in up to 3% of retrocolic bypass procedures)PresentationMost common in first 6-18 months post-operatively Presents with colicky Epigastric Pain that worsens with eating Occurs in those with the greatest weight loss EvaluationRequires immediate surgical consultation Consider abdominal CT if suspected
Complications: Short-termWound infectionOccurs up to 3 weeks after surgery Risk of developing Incisional Hernia Stomal stenosisResults in Vomiting even with liquid meals Evaluate Upper gastrointestinal series Treat with dilatation via upper endoscopy Peptic ulcer at surgical anastomosis (marginal ulcer)Evaluate with upper endoscopy Avoid NSAID s Constipation Maximize hydration (96 ounces clear fluid daily) Minimize Narcotic Analgesic s post-operatively Avoid Bulk Laxative s after gastric bandingRisk of obstruction
Complications: Long-termCholelithiasis or Cholecystitis (30% of patients)Consider Cholecystectomy at time of Bariatric Surgery Nephrolithiasis related to Calcium Oxalate Stone formationSecondary Hyperparathyroidism MalabsorptionSee lab monitoring below See post-operative diet below Dumping Syndrome (60% of patients) Protein-calorie malnutrition Fat malabsorption Lactose Intolerance Beef intolerance (due to heightened sense of taste and smell) Calcium malabsorption Micronutrient deficiency (Copper deficiency, Zinc Deficiency ) Vitamin A deficiencyAnemia due to Vitamin Deficiency Iron Deficiency Anemia Folate Deficiency Vitamin B12 Deficiency Overall body changesHair thinning (due to rapid weight loss)Supplement with more dietary protein Consider Biotin Metrorrhagia Fertility increasesUse reliable Contraception to avoid pregnancy within first 2 years after surgery Food intoleranceLactose Intolerance Beef intolerance (due to hypersensitivity to taste and smell) Altered medication absorptionGastric banding (gastric restriction)Consider switch from XR to immediate release agents Take one medication at a time Gastric BypassMonitor Digoxin and Levothyroxine dosing closely Exercise caution when using Azole Antifungal s Bacterial overgrowthPresents with abdominal distention, proctitis, nighttime Diarrhea , and arthralgias Panus: Paniculectomy indicationsRefractory skin irritation Panus severe enough to cover genitalia
EfficacyBariatric Surgery may cure diabetes in morbid Obesity Rubino (2002) Ann Surg 236:554-9 Significantly reduces morbidity and mortalityDiabetes Mellitus 76% resolved or improvedTotal and LDL Cholesterol was significantly reduced Hypertension resolved in 61% (improved in 78%)Sleep Apnea resolved or improved in 83%Mortality over 9 years reduced from 28% to 9% Buchwald (2004) JAMA 292:1724-37
Labs: Preoperative evaluationComprehensive metabolic panel (renal and hepatic panel) Complete Blood Count with plateletsCoagulation studies (INR and PTT) Fasting lipid panel Thyroid Stimulating Hormone Vitamin D (25-hydroxyvitamin D)Vitamin B12 Vitamin B6 Vitamin B1 Urinalysis Chest XRay Electrocardiogram
Labs: Monitoring schedule post-procedureThree months after surgeryComplete Blood Count Blood Glucose Serum Creatinine Six months after surgeryComplete Blood Count Blood Glucose Serum Creatinine Serum Calcium Liver Function Test sSerum Protein Serum Albumin Serum Ferritin Serum Vitamin B12 Serum Folic Acid Nine months after surgeryComplete Blood Count Blood Glucose Serum Creatinine One year after surgery and then every year therafterComplete Blood Count Blood Glucose Serum Creatinine Serum Ferritin Serum Vitamin B12 Serum Vitamin D Serum Vitamin A Other labs to considerSerum Thiamine Serum Copper Serum Zinc Serum Magnesium Serum Vitamin B6
Management: Pre-operative EvaluationPreoperative bariatric evaluation is identical to that in non-obese, non-Bariatric Surgery patientsExceptions: Obstructive Sleep Apnea and Venous Thromboembolism Obstructive Sleep Apnea (not yet evaluated)Uncontrolled Sleep Apnea is a significant risk factor for anastomotic leak Obstructive Sleep Apnea Prevalence approaches 75% of patients pursuing Bariatric SurgeryDelay procedure for Sleep Apnea evaluation with formal polysomonographyIf positive for Sleep Apnea , start CPAP and delay surgery for 4 weeks Venous Thromboembolism prophylaxisCommon (1-3%) and a leading cause of mortality following Bariatric Surgery Risk FactorsBody Mass Index >60 kg/m2Chronic Leg Edema Obstructive Sleep Apnea Prior thromboembolism Best prophylactic strategy is unclearRemovable IVC Filters are commonly used in high risk patients (but inadequate evidence) Reasonable strategyWell-fitted Compression stockings Early ambulation Enoxaparin 30 mg bid (40 mg bid if BMI>50)Consider removable IVC Filter for high risk patients
Management: Diet post-operativeDietary changes to avoid over-distention and Vomiting Immediately after Gastric BypassStart with clear liquids and gradually progress to regular foods over first 3 months LongtermStart meal with protein portion to ensure adequate protein intake Cut food into small bite size amounts (as if using toddler utensils) Chew well (to applesauce consistency) before swallowing Eat slowly and without distraction (finish a meal within 30 minutes) Avoid drinking fluids 30 minutes before and 30-60 minutes after each meal Identify fullness sensation and stop eating immediately when you feel this Other dietary changesLimits foods with substantial simple carbohydrates or high fats (avoids dumping) Stay hydrated by taking 64 ounces non-caffeinated fluid and avoiding Alcohol Vitamin supplementationMultivitamin chewable once to twice daily (twice if status-post roux-en-y) Vitamin B12 Supplementation (1000 mcg IM monthly or 350 mcg orally daily)Calcium 1200 to 1500 mg daily Vitamin D 800 IU daily (2000 IU daily if status-post roux-en-y)Iron Supplementation 18-27 mg/day (higher in menstruating women)Maintain adequate dietary protein intake (see above) Additional supplements if deficiency identified (recheck monthly until normal)Thiamine 50 mg orally daily for 6 monthsVitamin B6 50 mg orally dailyFolate 1 mg orally daily
Follow-up: Post-operativeImperative that patients continue life-long careCompliance with diet above Maintenance of regular physical Exercise program Monitoring of labs (see above) PregnancyDelay pregnancy for >18-24 months post-procedure SupplementProtein: Additional extra 10 grams per day Vitamin B12 : 1000 mcg sublingual weeklyFolic Acid 800 mg orally dailyIron 325 mg orally dailyVitamin C 500 mg orally dailyCalcium 1200 mg orally daily Prevent additional weight loss and expect weight gain during pregnancy Consider adjustment of band pressure Continued education and reevaluationDieticians Nurses Surgical follow-up
ReferencesBalsiger (2000) Mayo Clin Proc 75:673-80 Buchwald (2004) JAMA 292:1724-37 Choban (1997) J Am Coll Surg 185:593-603 Virji (2006) Am Fam Physician 73:1403-8 Schroeder (2011) Am Fam Physician 84(7): 805-14